|
1.
|
Archie V, Kauh J, Jones DV Jr, Cruz V,
Karpeh MS Jr and Thomas CR Jr: Gastric cancer: standards for the
21st century. Crit Rev Oncol Hematol. 57:123–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar
|
|
3.
|
Yeh KH and Cheng AL: Recent advances in
therapy for gastric cancer. J Formos Med Assoc. 103:171–185.
2004.
|
|
4.
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006.PubMed/NCBI
|
|
5.
|
Vital and Health Statistics Division,
Statistics and Information Department, Ministry of Health, Labour
and Welfare: Vital statistics in Japan (1950–2007.
|
|
6.
|
Horner MJ, Ries LAG, Krapcho M, Neyman N,
Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A,
Miller BA, Lewis DR, Eisner MP, Stinchcomb DG and Edwards BK: SEER
Cancer statistics review, 1975–2006. National Cancer Institute;
Bethesda: 2008
|
|
7.
|
Lee KH, Lee JH, Cho JK, Kim TW, Kang YK,
Lee JS, Kim WK, Chung JG, Lee IC and Sun HS: A prospective
correlation of Laurén’s histological classification of stomach
cancer with clinicopathological findings including DNA flow
cytometry. Pathol Res Pract. 197:223–229. 2001.
|
|
8.
|
Whiting J, Sano T, Saka M, Fukagawa T,
Katai H and Sasako M: Follow-up of gastric cancer: a review.
Gastric Cancer. 9:74–81. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
The EUROCARE-4 database on cancer survival
in Europe. [http://www.eurocare.it/Results/tabid/79/Default.aspx#eu4dB].
|
|
10.
|
Guarino M: Epithelial-mesenchymal
transition and tumour invasion. Int J Biochem Cell Biol.
39:2153–2160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ,
Chen CJ, Chi NH, Chen GH and Lin JT: Elevated plasma osteopontin
associated with gastric cancer development, invasion and survival.
Gut. 56:782–789. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y
and Tahara E: Aberrant expression of c-met mRNA in human gastric
carcinomas. Int J Cancer. 55:72–75. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Ran Y, Peng L, Hu H, Yu L, Liu Q, Zhou Z,
Sun YM, Sun LC, Pan J, Sun LX, Zhao P and Yang ZH: Secreted LOXL2
is a novel therapeutic target that promotes gastric cancer
metastasis via the Src/FAK pathway. Carcinogenesis. 30:1660–1669.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kim JH, Kim MA, Lee HS and Kim WH:
Comparative analysis of protein expressions in primary and
metastatic gastric carcinomas. Hum Pathol. 40:314–322. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Gravalos C and Jimeno A: HER2 in gastric
cancer: a new prognostic factor and a novel therapeutic target. Ann
Oncol. 19:1523–1529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sakashita K, Mimori K, Tanaka F, Kamohara
Y, Inoue H, Sawada T, Hirakawa K and Mori M: Prognostic relevance
of Tensin4 expression in human gastric cancer. Ann Surg Oncol.
15:2606–2613. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Yu G, Wang J, Chen Y, Wang X, Pan J, Li G,
Jia Z, Li Q, Yao JC and Xie K: Overexpression of phosphorylated
mammalian target of rapamycin predicts lymph node metastasis and
prognosis of Chinese patients with gastric cancer. Clin Cancer Res.
15:1821–1829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Nakayama H, Yasui W, Yokozaki H and Tahara
E: Reduced expression of nm23 is associated with metastasis of
human gastric carcinomas. Jpn J Cancer Res. 84:184–190. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Okada K, Shimura T, Suehiro T, Mochiki E
and Kuwano H: Reduced galectin-3 expression is an indicator of
unfavorable prognosis in gastric cancer. Anticancer Res.
26:1369–1376. 2006.PubMed/NCBI
|
|
20.
|
Li X, Zhang Y, Cao S, Chen X, Lu Y, Jin H,
Sun S, Chen B, Liu J, Ding J, Wu K and Fan D: Reduction of TIP30
correlates with poor prognosis of gastric cancer patients and its
restoration drastically inhibits tumor growth and metastasis. Int J
Cancer. 124:713–721. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Hsu PI, Hsieh HL, Lee J, Lin LF, Chen HC,
Lu PJ and Hsiao M: Loss of RUNX3 expression correlates with
differentiation, nodal metastasis, and poor prognosis of gastric
cancer. Ann Surg Oncol. 16:1686–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kim DY, Joo JK, Park YK, Ryu SY, Kim HS,
Noh BK, Lee HK and Lee HJ: E-cadherin expression in early gastric
carcinoma and correlation with lymph node metastasis. J Surg Oncol.
96:429–435. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hippo Y, Yashiro M, Ishii M, Taniguchi H,
Tsutsumi S, Hirakawa K, Kodama T and Aburatani H: Differential gene
expression profiles of scirrhous gastric cancer cells with high
metastatic potential to peritoneum or lymph nodes. Cancer Res.
61:889–895. 2001.PubMed/NCBI
|
|
24.
|
Wang J and Chen S: Screening and
identification of gastric adenocarcinoma metastasis-related genes
using cDNA micro-array coupled to FDD-PCR. J Cancer Res Clin Oncol.
128:547–553. 2002. View Article : Google Scholar
|
|
25.
|
Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO,
Kim JH, Song KS, Rho SM, Yoo HS, Kim YS, Kim JG and Kim NS:
Identification of gastric cancer-related genes using a cDNA
microarray containing novel expressed sequence tags expressed in
gastric cancer cells. Clin Cancer Res. 11:473–482. 2005.PubMed/NCBI
|
|
26.
|
Myllykangas S, Junnila S, Kokkola A, Autio
R, Scheinin I, Kiviluoto T, Karjalainen-Lindsberg ML, Hollmén J,
Knuutila S, Puolakkainen P and Monni O: Integrated gene copy number
and expression microarray analysis of gastric cancer highlights
potential target genes. Int J Cancer. 123:817–825. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Hippo Y, Taniguchi H, Tsutsumi S, Machida
N, Chong JM, Fukayama M, Kodama T and Aburatani H: Global gene
expression analysis of gastric cancer by oligonucleotide
microarrays. Cancer Res. 62:233–240. 2002.PubMed/NCBI
|
|
28.
|
Inoue H, Matsuyama A, Mimori K, Ueo H and
Mori M: Prognostic score of gastric cancer determined by cDNA
microarray. Clin Cancer Res. 8:3475–3479. 2002.PubMed/NCBI
|
|
29.
|
Hasegawa S, Furukawa Y, Li M, Satoh S,
Kato T, Watanabe T, Katagiri T, Tsunoda T, Yamaoka Y and Nakamura
Y: Genome-wide analysis of gene expression in intestinal-type
gastric cancers using a complementary DNA microarray representing
23,040 genes. Cancer Res. 62:7012–7017. 2002.PubMed/NCBI
|
|
30.
|
Yang S, Jeung HC, Jeong HJ, Choi YH, Kim
JE, Jung JJ, Rha SY, Yang WI and Chung HC: Identification of genes
with correlated patterns of variations in DNA copy number and gene
expression level in gastric cancer. Genomics. 89:451–459. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Chang W, Ma L, Lin L, Gu L, Liu X, Cai H,
Yu Y, Tan X, Zhai Y, Xu X, et al: Identification of novel hub genes
associated with liver metastasis of gastric cancer. Int J Cancer.
125:2844–2853. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Oue N, Aung PP, Mitani Y, Kuniyasu H,
Nakayama H and Yasui W: Genes involved in invasion and metastasis
of gastric cancer identified by array-based hybridization and
serial analysis of gene expression. Oncology. 69:17–22. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Motoyama T, Hojo H and Watanabe H:
Comparison of seven cell lines derived from human gastric
carcinomas. Acta Pathol Jpn. 36:65–83. 1986.PubMed/NCBI
|
|
34.
|
Yokozaki H: Molecular characteristics of
eight gastric cancer cell lines established in Japan. Pathol Int.
50:767–777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix
MJ, Wu R and Wu CW: Selection of invasive and metastatic
subpopulations from a human lung adenocarcinoma cell line. Am J
Respir Cell Mol Biol. 17:353–360. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Huang YC, Chen CT, Chen SC, Lai PH, Liang
HC, Chang Y, Yu LC and Sung HW: A natural compound (Ginsenoside Re)
isolated from Panax Ginseng as a novel angiogenic agent for tissue
regeneration. Pharm Res. 22:636–646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Li WT, Hwang DR, Chen CP, Shen CW, Huang
CL, Chen TW, Lin CH, Chang YL, Chang YY, Lo YK, et al: Synthesis
and biological evaluation of N-heterocyclic indolyl glyoxylamides
as orally active anticancer agents. J Med Chem. 46:1706–1715. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Tuan TF, Tsai ML, Yeh KC, Huang HC, Chung
CT, Huang CL, Han CH, Chen CP, Wang MH, Shen CC, et al: Intravenous
paclitaxel against metastasis of human gastric tumors of diffuse
type. Cancer Chemother Pharmacol. 66:773–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
40.
|
Chen X, Leung SY, Yuen ST, Chu KM, Ji J,
Li R, Chan AS, Law S, Troyanskaya OG, Wong J, So S, Botstein D and
Brown PO: Variation in gene expression patterns in human gastric
cancers. Mol Biol Cell. 14:3208–3215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Hansson LE, Engstrand L, Nyrén O, Evans DJ
Jr, Lindgren A, Bergström R, Andersson B, Athlin L, Bendtsen O and
Tracz P: Helicobacter pylori infection: independent risk indicator
of gastric adenocarcinoma. Gastroenterology. 105:1098–1103.
1993.PubMed/NCBI
|
|
42.
|
Piazuelo MB, Epplein M and Correa P:
Gastric cancer: an infectious disease. Infect Dis Clin North Am.
24:853–869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Ferreira AC, Isomoto H, Moriyama M,
Fujioka T, Machado JC and Yamaoka Y: Helicobacter and gastric
malignancies. Helicobacter. 13(Suppl 1): 28–34. 2008. View Article : Google Scholar
|
|
44.
|
Suganuma M, Kuzuhara T, Yamaguchi K and
Fujiki H: Carcinogenic role of tumor necrosis factor-alpha inducing
protein of Helicobacter pylori in human stomach. J Biochem Mol
Biol. 39:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006.
|
|
46.
|
Chan AO, Lam SK, Wong BC, Wong WM, Yuen
MF, Yeung YH, Hui WM, Rashid A and Kwong YL: Promoter methylation
of E-cadherin gene in gastric mucosa associated with Helicobacter
pylori infection and in gastric cancer. Gut. 52:502–506. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Iwamoto J, Mizokami Y, Takahashi K,
Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T,
Shimokobe K, Ito M, Takehara H and Matsuoka T: Expressions of
urokinase-type plasminogen activator, its receptor and plasminogen
activator inhibitor-1 in gastric cancer cells and effects of
Helicobacter pylori. Scand J Gastroenterol. 40:783–793. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Schmausser B, Endrich S, Brändlein S,
Schär J, Beier D, Müller-Hermelink HK and Eck M: The chemokine
receptor CCR7 is expressed on epithelium of non-inflamed gastric
mucosa, Helicobacter pylori gastritis, gastric carcinoma and its
precursor lesions and up-regulated by H. pylori. Clin Exp Immunol.
139:323–327. 2005. View Article : Google Scholar
|
|
49.
|
Yasumoto K, Koizumi K, Kawashima A, Saitoh
Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi
Y, Yoshie O and Saiki I: Role of the CXCL12/CXCR4 axis in
peritoneal carcinomatosis of gastric cancer. Cancer Res.
66:2181–2187. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Zhao C, Lu X, Bu X, Zhang N and Wang W:
Involvement of tumor necrosis factor-alpha in the upregulation of
CXCR4 expression in gastric cancer induced by Helicobacter pylori.
BMC Cancer. 10:4192010. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Amoh Y, Katsuoka K and Hoffman RM:
Color-coded fluorescent protein imaging of angiogenesis: the
AngioMouse models. Curr Pharm Des. 14:3810–3819. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Bouvet M, Tsuji K, Yang M, Jiang P, Moossa
AR and Hoffman RM: In vivo color-coded imaging of the interaction
of colon cancer cells and splenocytes in the formation of liver
metastases. Cancer Res. 66:11293–11297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Hoffman RM: The multiple uses of
fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer.
5:796–806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Hoffman RM: Dual-color imaging of tumor
angiogenesis. Methods Mol Biol. 515:45–61. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Chen JJ, Peck K, Hong TM, Yang SC, Sher
YP, Shih JY, Wu R, Cheng JL, Roffler SR, Wu CW and Yang PC: Global
analysis of gene expression in invasion by a lung cancer model.
Cancer Res. 61:5223–5230. 2001.PubMed/NCBI
|
|
56.
|
Chen HY, Yu SL, Chen CH, Chang GC, Chen
CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, et al: A five-gene
signature and clinical outcome in non-small-cell lung cancer. N
Engl J Med. 356:11–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Dhar DK, Wang TC, Tabara H, Tonomoto Y,
Maruyama R, Tachibana M, Kubota H and Nagasue N: Expression of
trefoil factor family members correlates with patient prognosis and
neoangiogenesis. Clin Cancer Res. 11:6472–6478. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Rodrigues S, Van Aken E, Van Bocxlaer S,
Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FE, Thim L, Mareel
M, Gespach C and Emami S: Trefoil peptides as proangiogenic factors
in vivo and in vitro: implication of cyclooxygenase-2 and EGF
receptor signaling. FASEB J. 17:7–16. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Liu B, Lee KW, Anzo M, Zhang B, Zi X, Tao
Y, Shiry L, Pollak M, Lin S and Cohen P: Insulin-like growth
factor-binding protein-3 inhibition of prostate cancer growth
involves suppression of angiogenesis. Oncogene. 26:1811–1819. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Akhtar S, Meeran SM, Katiyar N and Katiyar
SK: Grape seed proanthocyanidins inhibit the growth of human
non-small cell lung cancer xenografts by targeting insulin-like
growth factor binding protein-3, tumor cell proliferation, and
angiogenic factors. Clin Cancer Res. 15:821–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Hansel DE, Rahman A, House M, Ashfaq R,
Berg K, Yeo CJ and Maitra A: Met proto-oncogene and insulin-like
growth factor binding protein 3 overexpression correlates with
metastatic ability in well-differentiated pancreatic endocrine
neoplasms. Clin Cancer Res. 10:6152–6158. 2004. View Article : Google Scholar
|
|
62.
|
Saaristo A, Karpanen T and Alitalo K:
Mechanisms of angiogenesis and their use in the inhibition of tumor
growth and metastasis. Oncogene. 19:6122–6129. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Iwai K, Hirata K, Ishida T, Takeuchi S,
Hirase T, Rikitake Y, Kojima Y, Inoue N, Kawashima S and Yokoyama
M: An anti-proliferative gene BTG1 regulates angiogenesis in vitro.
Biochem Biophys Res Commun. 316:628–635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Fisk HA, Mattison CP and Winey M: A field
guide to the Mps1 family of protein kinases. Cell Cycle. 3:439–442.
2004.PubMed/NCBI
|
|
65.
|
Dorer RK, Zhong S, Tallarico JA, Wong WH,
Mitchison TJ and Murray AW: A small-molecule inhibitor of Mps1
blocks the spindle-checkpoint response to a lack of tension on
mitotic chromosomes. Curr Biol. 15:1070–1076. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
Poss KD, Nechiporuk A, Stringer KF, Lee C
and Keating MT: Germ cell aneuploidy in zebrafish with mutations in
the mitotic checkpoint gene mps1. Genes Dev. 18:1527–1532. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Takayama T, Miyanishi K, Hayashi T, Sato Y
and Niitsu Y: Colorectal cancer: genetics of development and
metastasis. J Gastroenterol. 41:185–192. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Naderi A, Liu J and Bennett IC: BEX2
regulates mitochondrial apoptosis and G1 cell cycle in breast
cancer. Int J Cancer. 126:1596–1610. 2010.PubMed/NCBI
|
|
69.
|
Chen PS, Wang MY, Wu SN, Su JL, Hong CC,
Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, et al: CTGF enhances the
motility of breast cancer cells via an
integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. J
Cell Sci. 120:2053–2065. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Bracke ME, Van Roy FM and Mareel MM: The
E-cadherin/catenin complex in invasion and metastasis. Curr Top
Microbiol Immunol. 213:123–161. 1996.PubMed/NCBI
|
|
71.
|
Mauro L, Bartucci M, Morelli C, Ando S and
Surmacz E: IGF-I receptor-induced cell-cell adhesion of MCF-7
breast cancer cells requires the expression of junction protein
ZO-1. J Biol Chem. 276:39892–39897. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
Qin J, Feng M, Wang C, Ye Y, Wang PS and
Liu C: Oxytocin receptor expressed on the smooth muscle mediates
the excitatory effect of oxytocin on gastric motility in rats.
Neurogastroenterol Motil. 21:430–438. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73.
|
Morita T, Shibata K, Kikkawa F, Kajiyama
H, Ino K and Mizutani S: Oxytocin inhibits the progression of human
ovarian carcinoma cells in vitro and in vivo. Int J Cancer.
109:525–532. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
74.
|
Meyer zum Büschenfelde D, Hoschützky H,
Tauber R and Huber O: Molecular mechanisms involved in TFF3
peptide-mediated modulation of the E-cadherin/catenin cell adhesion
complex. Peptides. 25:873–883. 2004.PubMed/NCBI
|
|
75.
|
Ortega P, Moran A, Fernandez-Marcelo T, De
Juan C, Frias C, Lopez-Asenjo JA, Sanchez-Pernaute A, Torres A,
Diaz-Rubio E, Iniesta P and Benito M: MMP-7 and SGCE as distinctive
molecular factors in sporadic colorectal cancers from the mutator
phenotype pathway. Int J Oncol. 36:1209–1215. 2010.PubMed/NCBI
|
|
76.
|
Patarroyo M, Tryggvason K and Virtanen I:
Laminin isoforms in tumor invasion, angiogenesis and metastasis.
Semi Cancer Biol. 12:197–207. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
77.
|
Wang J, Levenson AS and Satcher RL Jr:
Identification of a unique set of genes altered during cell-cell
contact in an in vitro model of prostate cancer bone
metastasis. Int J Mol Med. 17:849–856. 2006.PubMed/NCBI
|
|
78.
|
Xi Y, Nakajima G, Hamil T, Fodstad O,
Riker A and Ju J: Association of insulin-like growth factor binding
protein-3 expression with melanoma progression. Mol Cancer Ther.
5:3078–3084. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
79.
|
Torng PL, Lee YC, Huang CY, Ye JH, Lin YS,
Chu YW, Huang SC, Cohen P, Wu CW and Lin CT: Insulin-like growth
factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis
suppressor in ovarian endometrioid carcinoma. Oncogene.
27:2137–2147. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
80.
|
Gao Y, Kitagawa K, Hiramatsu Y, Kikuchi H,
Isobe T, Shimada M, Uchida C, Hattori T, Oda T, Nakayama K,
Nakayama KI, Tanaka T, Konno H and Kitagawa M: Up-regulation of
GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell
invasiveness and metastasis. Cancer Res. 66:11623–11631. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
81.
|
D’Andrea AD and Grompe M: The Fanconi
anaemia/BRCA pathway. Nat Rev Cancer. 3:23–34. 2003.
|
|
82.
|
Schmidt J and Bosserhoff AK: Processing of
MIA protein during melanoma cell migration. Int J Cancer.
125:1587–1594. 2009. View Article : Google Scholar : PubMed/NCBI
|
